go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Arkansas rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $3,981 · 10th–90th $3,548$3,9810%50%10th$3,981Professionalmedian $3,548 · 10th–90th $3,467$4,1690%50%10th90th$3,548$2.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Aetna
Setting
Professional
Modifier
Global
Typical Low
$3,467.37
Median
$3,548.13
Typical High
$3,548.13
BCBS
Setting
Facility
Modifier
Global
Typical Low
$3,981.07
Median
$3,981.07
Typical High
$3,981.07
BCBS
Setting
Professional
Modifier
Global
Typical Low
$3,981.07
Median
$3,981.07
Typical High
$3,981.07
Cigna
Setting
Facility
Modifier
Global
Typical Low
$3,311.31
Median
$4,786.30
Typical High
$5,754.40
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
United
Setting
Professional
Modifier
Global
Typical Low
$3,981.07
Median
$4,168.69
Typical High
$4,365.16